Movement Alert|Oklo Inc. Rises 5.05% in Regular Trading, U.S. Army Janus Program Awards Up to $2.2 Billion for Military Micro-Reactors

Market Focus
Aug 28

On August 27, Oklo Inc. rose 5.05% in regular trading, trading at $43.61 per share, with turnover of $255 million. The rally was driven by the U.S. Army's formal launch of the Janus Program, which selected five nuclear energy companies to receive up to $2.2 billion in funding to build, own, and operate micro-reactors at military installations across five states.

The program aims to have the first Army-supervised reactor operational at a military facility by September 2028. Combined with anticipated private-sector investment, the Army expects to construct and operate more than 20 nuclear micro-reactors across Department of War facilities. Multiple nuclear stocks rallied on the news, with Nano Nuclear Energy surging 3.6% and NuScale Power gaining nearly 2% in pre-market trading.

Separately, the U.S. Department of Energy's National Reactor Innovation Center recently added Oklo to its Nuclear Energy Launchpad program, providing regulatory and technical support for advanced reactor commercialization. These policy catalysts partially offset recent headwinds including analyst earnings downgrades and executive share-sale filings totaling approximately $31 million.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10